Viewing StudyNCT02789332



Ignite Creation Date: 2024-05-06 @ 8:38 AM
Last Modification Date: 2024-10-26 @ 12:03 PM
Study NCT ID: NCT02789332
Status: COMPLETED
Last Update Posted: 2020-03-17
First Post: 2016-05-23

Brief Title: Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel Carboplatin Followed by EpirubicinCyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency
Sponsor: German Breast Group
Organization: German Breast Group

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-09
Start Date Type: ACTUAL
Primary Completion Date: 2019-02
Primary Completion Date Type: ACTUAL
Completion Date: 2020-02
Completion Date Type: ACTUAL
First Submit Date: 2016-05-23
First Submit QC Date: May 27 2016
Study First Post Date: 2016-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-03-13
Last Update Post Date: 2020-03-17
Last Update Post Date Type: ACTUAL